11/20
08:06 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
11/14
11:15 am
zvra
Rating for ZVRA
Medium
Report
Rating for ZVRA
10/11
01:50 pm
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
10/11
01:03 pm
zvra
Rating for ZVRA
Low
Report
Rating for ZVRA
10/7
01:15 pm
zvra
Rating for ZVRA
Low
Report
Rating for ZVRA
10/7
01:15 pm
zvra
Rating for ZVRA
Low
Report
Rating for ZVRA
10/7
09:01 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is now covered by analysts at Guggenheim. They set a "buy" rating and a $20.00 price target on the stock.
Medium
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is now covered by analysts at Guggenheim. They set a "buy" rating and a $20.00 price target on the stock.
10/7
09:01 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is now covered by analysts at Guggenheim. They set a "buy" rating and a $20.00 price target on the stock.
Medium
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is now covered by analysts at Guggenheim. They set a "buy" rating and a $20.00 price target on the stock.
10/1
08:46 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
10/1
08:34 am
zvra
Rating for ZVRA
Medium
Report
Rating for ZVRA
9/30
08:01 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
9/24
09:22 am
zvra
Rating for ZVRA
Medium
Report
Rating for ZVRA
9/24
09:22 am
zvra
Rating for ZVRA
Medium
Report
Rating for ZVRA
9/24
09:03 am
zvra
Rating for ZVRA
Low
Report
Rating for ZVRA
9/24
08:42 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $17.00 price target on the stock.
Medium
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $17.00 price target on the stock.
9/24
08:42 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $17.00 price target on the stock.
Medium
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $17.00 price target on the stock.
9/18
02:55 pm
zvra
Rating for ZVRA
Low
Report
Rating for ZVRA
9/6
07:02 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) was upgraded by analysts at William Blair to a "strong-buy" rating.
Low
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) was upgraded by analysts at William Blair to a "strong-buy" rating.
9/6
07:02 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) was upgraded by analysts at William Blair to a "strong-buy" rating.
Low
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) was upgraded by analysts at William Blair to a "strong-buy" rating.